• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>PNC Capital Trust E Pref Share

PNC Capital Trust E Pref Share

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. FDA Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH )

    FDA Grants Orphan Drug Designation to ALXN1210 for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria ( PNH )

  2. DEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Alexion ...

    DEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Alexion Pharmaceuticals, Inc. To Contact The Firm

  3. Yen’s Shifting Value Helps Japanese Carmakers Meet New Challenges

    We think Alexion will have the PNH market cornered.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.